Developing a quality by design approach to model tablet dissolution testing: an industrial case study

References

• Basalious EB, El-Sebaie W, El-Gazayerly O. 2011. Application of Pharmaceutical QbD for enhancement of the solubility and dissolution of a Class II BCS drug using Polymeric Surfactants and Crystallization Inhibitors: development of controlled-release tablets. AAPS PharmSciTech. 12:799–810.
   PubMed Web of Science ®Google Scholar
• Buri P. 1983. Mesure de la vitesse de dissolution pour l'amélioration et le contrôle de la qualité des médicaments [Measurement of dissolution rate for drug quality improvement and control]. J Pharm Biomed Anal. 1:393–402.
   PubMedGoogle Scholar
• Costa P, Sousa Lobo JM. 2001. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 13:123–133.
   PubMed Web of Science ®Google Scholar
• Cui Y, Song X, Reynolds M, Chuang K, Xie M. 2012. Interdependence of drug substance physical properties and corresponding quality control strategy. J Pharm Sci. 101:312–321.
   PubMed Web of Science ®Google Scholar
• Dokoumetzidis A, Papadopoulou V, Macheras P. 2006. Analysis of dissolution data using modified versions of Noyes–Whitney equation and the Weibull function. Pharm Res. 23:256–261.
   PubMed Web of Science ®Google Scholar
• Dressman J, Kramer J. (2005). Pharmaceutical Dissolution testing (Vol. 140 of Drugs and Pharmaceutical Sciences Series). New York: Taylor and Francis.
   Google Scholar
• Dumarey M, Goodwin DJ, Davison C. 2015. Multivariate modelling to study the effect of the manufacturing process on the complete tablet dissolution profile. Int J Pharm. 486:112–120.
   PubMed Web of Science ®Google Scholar
• FDA. 1997. Dissolution Testing of Immediate Release Solid Oral Dosage Forms [Internet]. Rockville, MD: Guidance for industry. [cited 216 Dec 31]. Available from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070237.pdf
   Google Scholar
• FDA and EMEA. 2013. Questions and Answers on Design Space Verification [Internet]. [cited 216 Dec 31]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2013/11/WC500153784.pdf
   Google Scholar
• Hernandez E, Pawar P, Keyvan G, Wang Y, Velez N, Callegari G, Cuitino A, Michniak-Kohn B, Muzzio FJ, Romañach RJ. 2016. Prediction of dissolution profiles by non-destructive near infrared spectroscopy in tablets subjected to 148 different levels of strain. J Pharm Biomed Anal. 117:568–565.
   PubMed Web of Science ®Google Scholar
• Higuchi, T. 1963. Mechanism of sustained-action medication theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Hixson AW, Crowell JH. 1931. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem. 23:923–931.
   Google Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2003 Stability Testing of New Drug Substance and Products Q1A(R2). Rockville, MD: Guidance for Industry.
   Google Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2009. Pharmaceutical Development Q8 (R2). Rockville, MD: Guidance for Industry.
   Google Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2011a. Quality Risk Management, Q9. Rockville, MD: Guidance for Industry.
   Google Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2011b. Pharmaceutical Quality System, Q10. Rockville, MD: Guidance for Industry.
   Google Scholar
• International Conference on Harmonisation Quality Implementation Working Group Points To Consider (R2). 2011c. International Conference on Harmonisation – Endorsed Guide for ICH Q8/Q9/Q10 Implementation. Rockville, MD: Guidance for Industry.
   Google Scholar
• Juenemann D, Jantratid E, Wagner C, Reppas C, Vertzoni M, Dressman JB. 2011. Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles. Eur J Pharm Biopharm. 77:257–264.
   PubMed Web of Science ®Google Scholar
• Juran JM. (1992). Juran on quality by design: the new steps for planning quality into goods and services. New York (NY): The Free Press.
   Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci. 72:1189–1191.
   PubMed Web of Science ®Google Scholar
• Le Hir A, Chaumeil J-C, Brossard D. (2009). Pharmacie Galénique: Bonnes pratiques de fabrication des médicaments. Paris: Elsevier Masson.
   Google Scholar
• Little T. 2013. Essentials in establishing and using design space. BioPharm Int. 26:50–54. Available from http://www.biopharminternational.com/essentials-establishing-and-using-design-space
   Web of Science ®Google Scholar
• Noyes AA, Whitney WR. 1897. The rate of solution of solid substances in their own solutions. J Am Chem Soc. 19:930–934.
   Google Scholar
• Polli JE, Rekhi GS, Augsburger LL, Shah VP. 1997. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci. 86:690–700.
   PubMed Web of Science ®Google Scholar
• Rathore A, Saleki-Gerhardt A, Montgomery S, Tyler S. 2009. Quality by design: industrial case studies on defining and implementing design space for pharmaceutical processes part 2. Biopharm Int. 22:41–47.
   Web of Science ®Google Scholar
• Smith J. 2015. Research Works. Remington Education. Phys Pharm. 86:31–50.
   Google Scholar
• Yekpe K, Abatzoglou N, Bataille B, Gosselin R, Sharkawi T, Simard J-S, Cournoyer A. 2015. Predicting the dissolution behavior of pharmaceutical tablets with NIR chemical imaging. Int J Pharm. 486:242–251.
   PubMedGoogle Scholar
• Yu LX. 2008. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res. 25:781–791.
   PubMed Web of Science ®Google Scholar
• Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, Woodcock J. 2014. Understanding pharmaceutical quality by design. AAPS J. 16:771–783.
   PubMed Web of Science ®Google Scholar